Erratum: Disruption of the actin cytoskeleton results in nuclear factor-κB activation and inflammatory mediator production in cultured human intestinal epithelial cells (Journal of Cellular Physiology (2004) (71-81) DOI:10.1002/jcp.10477);Disruption of the actin cytoskeleton results in nuclear factor-κB activation and inflammatory mediator production in cultured human intestinal epithelial cells

Journal of Cellular Physiology

Volumn 200, Issue 1, 2004, Pages 71-81

  Németh, Zoltán H ^a   Deitch, Edwin A ^a   Davidson, Marson T ^a   Szabó, Csaba ^a   Vizi, E Sylvester ^b   Haskó, György ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; COMPLEMENTARY DNA; CYTOCHALASIN D; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LATRUNCULIN B; MITOGEN ACTIVATED PROTEIN KINASE P38; RNA;

ARTICLE; CANCER CELL CULTURE; COLON CANCER; CYTOSKELETON; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE EPITHELIUM CELL; MICROTUBULE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EUKARYOTA;

EID: 2642515740     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20117     Document Type: Erratum

References (47)

1. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. 1994. The cytoskeleton. Molecular biology of the cell. New York, NY: Garland Publishing, Inc.
2. Aoki T, Sano Y, Yamamoto T, Inoue JI. 1996. The ankyrin repeats but not the PEST-like sequences are required for signal-dependent degradation of IκBβ. Oncogene 12:1159-1164.
3. Are AF, Galkin VE, Pospelova TV, Pinaev GP. 2000. The p65/RelA subunit of NF-κB interacts with actin-containing structures. Exp Cell Res 256:533-544.
4. Aschner M, Aschner JL. 1992. Cellular and molecular effects of trimethyltin and triethyltin: Relevance to organotin neurotoxicity. Neurosci Biobehav Rev 16:427-435.
5. Baeuerle PA. 1998. IκB-NF-κB structures: At the interface of inflammation control. Cell 95:729-731.
6. Banan A, Zhang Y, Losurdo J, Keshavarzian A. 2000. Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line. Gut 46:830-837.
7. Banan A, Farhadi A, Fields JZ, Mutlu E, Zhang L, Keshavarzian A. 2003. Evidence that nuclear factor-κB activation is critical in oxidant-induced disruption of the microtubule cytoskeleton and barrier integrity and that its inactivation is essential in epidermal growth factor-mediated protection of the monolayers of intestinal epithelia. J Pharmacol Exp Ther 306:13-28.
8. Ben-Ze'ev A. 1991. Animal cell shape changes and gene expression. Bioessays 13:207-212.
9. Blank V, Kourilsky P, Israel A. 1992. NF-κB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem Sci 17:135-140.
10. Bourgarel-Rey V, Vallee S, Rimet O, Champion S, Braguer D, Desobry A, Briand C, Barra Y. 2001. Involvement of nuclear factor κB in c-Myc induction by tubulin polymerization inhibitors. Mol Pharmacol 59:1165-1170.
11. Böcker U, Schottelius A, Watson JM, Holt L, Licato LL, Brenner DA, Sartor RB, Jobin C. 2000. Cellular differentiation causes a selective down-regulation of interleukin (IL)-1β-mediated NF-κB activation and IL-8 gene expression in intestinal epithelial cells. J Biol Chem 275:12207-12213.
12. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK. 2000. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 164:966-972.
13. Cooper JA. 1987. Effects of cytochalasin and phalloidin on actin. J Cell Biol 105:1473-1478.
14. Crepieux P, Kwon H, Leclerc N, Spencer W, Richard S, Lin R, Hiscott J. 1997. IκB alpha physically interacts with a cytoskeleton-associated protein through its signal response domain. Mol Cell Biol 17:7375-7385.
15. Davis JQ, Bennett V. 1984. Brain ankyrin. A membrane-associated protein with binding sites for spectrin, tubulin, and the cytoplasmic domain of the erythrocyte anion channel. J Biol Chem 25:13550-13559.
16. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DR. 2002. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 17:525-535.
17. Donelli G, Fabbri A, Fiorentini C. 1996. Bacteroides fragilis enterotoxin induces cytoskeletal changes and surface blebbing in HT-29 cells. Infect Immun 64:113-119.
18. Elewaut D, DiDonato JA, Kim JM, Truong F, Eckmann L, Kagnoff MF. 1999. NF-κB is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. J Immunol 163:1457-1466.
19. Feinman R, Clarke KO, Harrison LE. 2002. Phenylbutyrate-induced apoptosis is associated with inactivation of NF-κB in HT-29 colon cancer cells. Cancer Chemother Pharmacol 49:27-34.
20. Feltis BA, Kim AS, Kinneberg KM, Lyerly DL, Wilkins TD, Erlandsen SL, Wells CL. 1999. Clostridium difficile toxins may augment bacterial penetration of intestinal epithelium. Arch Surg 134: 1235-1241.
21. Frixione E. 2000. Recurring views on the structure and function of the cytoskeleton: A 300-year epic. Cell Motil Cytoskeleton 46:73-94.
22. Ghosh S, Karin M. 2002. Missing pieces in the NF-κB puzzle. Cell 109:S81-S96.
23. Giancotti FG, Ruoslahti E. 1999. Integrin signaling. Science 285: 1028-1032.
24. He D, Sougioultzis S, Hagen S, Liu J, Keates S, Keates AC, Pothoulakis C, Lamont JT. 2002. Clostridium difficile toxin A triggers human colonocyte IL-8 release via mitochondrial oxygen radical generation. Gastroenterology 122:1048-1057.
25. Hecht G, Pothoulakis C, LaMont JT, Madara JL. 1988. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest 82:1516-1524.
26. Hobbie S, Chen LM, Davis RJ, Galan JE. 1997. Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J Immunol 159: 5550-5559.
27. Jobin C, Haskill S, Mayer L, Panja A, Sartor RB. 1997. Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. J Immunol 158:226-234.
28. Kheradmand F, Werner E, Tremble P, Symons M, Werb Z. 1998. Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science 280:898-902.
29. Lee JC, Kassis S, Kumar S, Badger A, Adams JL. 1999. p38 mitogen-activated protein kinase inhibitors-Mechanisms and therapeutic potentials. Pharmacol Ther 82:389-397.
30. Lux SE, John KM, Bennett V. 1990. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature 344: 36-42.
31. Madara JL, Barenberg D, Carlson S. 1986. Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: Further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity. J Cell Biol 102:2125-2136.
32. Marinovich M, Viviani B, Corsini E, Ghilardi F, Galli CL. 1996. NF-κB activation by triphenyltin triggers apoptosis in HL-60 cells. Exp Cell Res 226:98-104.
33. Mukaida N, Okamoto S, Ishikawa Y, Matsushima K. 1994. Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 56: 554-558.
34. Musch MW, Sugi K, Straus D, Chang EB. 1999. Heat-shock protein 72 protects against oxidant-induced injury of barrier function of human colonic epithelial Caco2/bbe cells. Gastroenterology 117: 115-122.
35. Nilsen EM, Johansen F-E, Jahnsen FL, Lundin KEA, Scholz T, Brandtzaeg P, Haraldsen G. 1998. Cytokine profiles of cultured microvascular endothelial cells from the human intestine. Gut 42: 635-642.
36. Németh ZH, Deitch EA, Szabó C, Haskó G. 2002a. Hyperosmotic stress induces nuclear factor-κB activation and IL-8 production in human intestinal epithelial cells. Am J Pathol 161:987-996.
37. Németh ZH, Deitch EA, Szabó C, Fekete Z, Hauser CJ, Haskó G. 2002b. Lithium induces NF-κB activation and interleukin-8 production in human intestinal epithelial cells. J Biol Chem 277:7713-7719.
38. +/H' exchanger blockade inhibits enterocyte inflammatory response and protects against colitis. Am J Physiol Gastrointest Liver Physiol 283:G122-G132.
39. Rosette C, Karin M. 1995. Cytoskeletal control of gene expression: Depolymerization of microtubules activates NF-κB. J Cell Biol 128: 1111-1119.
40. Rosette C, Karin M. 1996. Ultraviolet light and osmotic stress: Activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274:1194-1197.
41. Saidi RF, Jaeger K, Montrose MH, Wu S, Sears CL. 1997. Bacteroides fragilis toxin rearranges the actin cytoskeleton of HT29/C1 cells without direct proteolysis of actin or decrease in F-actin content. Cell Motil Cytoskeleton 37:159-165.
42. Savkovic SD, Koutsouris A, Hecht G. 1997. Activation of NF-κB in intestinal epithelial cells by enteropathogenic Escherichia coli. Am J Physiol 273:C1160-C1167.
43. Senftleben U, Karin M. 2002. The IKK/NF-κB pathway. Crit Care Med 30:S18-S26.
44. Spector I, Braet F, Shochet NR, Bubb MR. 1999. New anti-actin drugs in the study of the organization and function of the actin cytoskeleton. Microsc Res Tech 47:18-37.
45. Subbaramaiah K, Hart JC, Norton L, Dannenberg AJ. 2000. Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen-activated protein kinase pathways. J Biol Chem 275: 14838-14845.
46. Wells CL, van de Westerlo EM, Jechorek RP, Haines HM, Erlandsen SL. 1998. Cytochalasin-induced actin disruption of polarized enterocytes can augment internalization of bacteria. Infect Immun 66:2410-2419.
47. Zhu P, Xiong W, Rodgers G, Qwarnstrom EE. 1998. Regulation of interleukin 1 signalling through integrin binding and actin reorganization: Disparate effects on NF-kappaB and stress kinase pathways. Biochem J 330:975-981.